Science 37 to Report First Quarter 2022 Financial Results
RESEARCH TRIANGLE PARK, N.C., April 25, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™...
Stay updated with breaking news from Science 37. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RESEARCH TRIANGLE PARK, N.C., April 25, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™...
Science 37 (NASDAQ:SNCE – Get Rating) and ProMIS Neurosciences (OTCMKTS:ARFXF – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Analyst Recommendations This is a breakdown of current recommendations […]
Science 37 Holdings Inc (NASDAQ:SNCE – Get Rating) shares dropped 8.6% during trading on Thursday . The company traded as low as $4.20 and last traded at $4.36. Approximately 10,826 shares traded hands during trading, a decline of 95% from the average daily volume of 235,376 shares. The stock had previously closed at $4.77. The […]
Science 37 Holdings Inc (NASDAQ:SNCE – Get Rating) gapped down before the market opened on Tuesday . The stock had previously closed at $5.66, but opened at $5.46. Science 37 shares last traded at $5.31, with a volume of 2,256 shares traded. The business has a 50-day simple moving average of $6.93. A number of […]
Science 37 Holdings Inc (NASDAQ:SNCE – Get Rating) – Investment analysts at William Blair issued their Q1 2023 earnings estimates for shares of Science 37 in a note issued to investors on Thursday, March 24th. William Blair analyst J. Kreger forecasts that the company will earn ($0.14) per share for the quarter. William Blair also […]